Date and Time:
The meeting will be held on November 28, 2001, 8:30 a.m. to 5:15 p.m., and on November 29, 2001, 8:30 a.m. to 2:30 p.m.
Location:
Holiday Inn, Versailles Ballrooms I and II, 8120 Wisconsin Avenue, Bethesda, MD 20814, 301-652-2000
Contact Person:
Nancy T. Cherry or Denise H. Royster, 301-827-0314 or FDA Advisory Committee Information Line, 1-800-741-8138, (301-443-0572 in the Washington, DC area), code 12391. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On November 28-29, 2001, the committee will review issues surrounding efficacy trial endpoints for Vaccines for the prevention of Human Papilloma Virus. On November 29, 2001, the committee will discuss the intramural scientific research of the Laboratory of Bacterial Toxins.
Oral Presentations:
Between approximately 3:15 and 4:15 p.m. on November 28, 2001, oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before November 16, 2001.
Closed Committee Deliberations:
On November 28, 2001, from 8:30 a.m. to 12:30 p.m., the meeting will be closed to permit discussion and review of trade secret and/or confidential information (5 U.S.C. 552b(c)(4)). On November 29, 2001, from 1:45 p.m. to 2:30 p.m., the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)).
